Key Points Non-GAAP earnings per share were $0.10 in Q2 2025, beating consensus estimates. Adjusted revenue rose 14%, slightly missing non-GAAP expectations but still reflecting strong testing ...

Key Financial and Operational Developments Zimmer Biomet delivered GAAP revenue of $2.077 billion, beating analysts' expectations on a non-GAAP basis. Growth was especially strong in the S.E.T.

(LLY) stock plunges as Phase 3 trial data for the company's oral weight loss drug orforglipron overshadow better than ...

However, non-GAAP financials are still governed by the SEC. In fact, the SEC has taken action in the past against companies that it believes are being too aggressive with non-GAAP numbers.

Shares of Datadog (DDOG) rose about 11% premarket on Thursday after second quarter results beat estimates and the company ...

Reports Q2 revenue $973M, consensus $932.42M. “We delivered revenue and adjusted EBITDA above the high end of our guidance, driven by strong year ...

Sees revenue $960M, plus or minus $40M, consensus $946.07M. Published first on TheFly – the ultimate source for real-time, market-moving breaking ...

While the company exceeded analyst expectations on several fronts, its Q3 outlook includes softer revenue and a slide back ...

Non-GAAP financial measures are used as a “complement,” like bread and butter, to supplement the earnings reported under GAAP. Because GAAP does not permit their inclusion in reported financial ...

IMGCAP (1)]The regulatory focus has sharpened recently on non-GAAP measures, by which I mean financial metrics, presented by companies outside the audited financial statements, that do not conform to ...